AKUM.Q Stock Overview
Akumin Inc. provides outpatient diagnostic imaging services in the United States.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Akumin Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.38 |
52 Week High | US$1.30 |
52 Week Low | US$0.12 |
Beta | 0.15 |
1 Month Change | 9.16% |
3 Month Change | 14.02% |
1 Year Change | -67.67% |
3 Year Change | -88.39% |
5 Year Change | -89.92% |
Change since IPO | -90.42% |
Recent News & Updates
Shareholder Returns
AKUM.Q | US Healthcare | US Market | |
---|---|---|---|
7D | -12.8% | -0.8% | 2.9% |
1Y | -67.7% | 1.7% | 22.2% |
Return vs Industry: AKUM.Q underperformed the US Healthcare industry which returned 0.3% over the past year.
Return vs Market: AKUM.Q underperformed the US Market which returned 15.8% over the past year.
Price Volatility
AKUM.Q volatility | |
---|---|
AKUM.Q Average Weekly Movement | 9.5% |
Healthcare Industry Average Movement | 7.3% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: AKUM.Q has not had significant price volatility in the past 3 months.
Volatility Over Time: AKUM.Q's weekly volatility has decreased from 25% to 10% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2015 | n/a | Riadh Zine Zine-El-Abidine | www.akumin.com |
Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other diagnostic and interventional radiology procedures through owned and/or operated imaging locations.
Akumin Inc. Fundamentals Summary
AKUM.Q fundamental statistics | |
---|---|
Market cap | US$34.19m |
Earnings (TTM) | -US$255.79m |
Revenue (TTM) | US$737.69m |
0.0x
P/S Ratio-0.1x
P/E RatioIs AKUM.Q overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AKUM.Q income statement (TTM) | |
---|---|
Revenue | US$737.69m |
Cost of Revenue | US$569.72m |
Gross Profit | US$167.97m |
Other Expenses | US$423.77m |
Earnings | -US$255.79m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -2.81 |
Gross Margin | 22.77% |
Net Profit Margin | -34.68% |
Debt/Equity Ratio | -1,459.1% |
How did AKUM.Q perform over the long term?
See historical performance and comparison